|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/76 | |
| A61K 35/765 | |||
| A61K 35/768 | |||
| A61P 35/00 | |||
| A61K 31/337 | |||
| A61K 31/555 |
| (11) | Patento numeris | 3068411 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14861625.3 |
| Europos patento paraiškos padavimo data | 2014-11-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2014/000806 |
| Data | 2014-11-12 |
| (87) | Numeris | WO 2015/070323 |
| Data | 2015-05-21 |
| (30) | Numeris | Data | Šalis |
| 201361904783 P | 2013-11-15 | US |
| (72) |
COFFEY, Matthew C., CA
THOMPSON, Bradley G., CA
|
| (73) |
Oncolytics Biotech Inc.,
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7,
CA
|
| (54) | ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS |
| ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS |